The Minnesota Cancer Clinical Trials Network, funded through MnDRIVE, will establish cancer clinical trial sites across Greater Minnesota.
Cancer patients in isolated corners of Minnesota will gain easier access to experimental medications, treatment protocols and prevention programs through a new state-funded cancer consortium launched Monday.
Led by the University of Minnesota and the Mayo Clinic, the consortium is a rare, high-profile partnership between two competing medical research giants.
Read the full story in the Star Tribune.